All data are based on the daily closing price as of October 30, 2025
l

L&C Bio

290650.KQ
37.48 USD
0.84
+2.29%

Overview

Last close
37.48 usd
Market cap
922.69M usd
52 week high
46.63 usd
52 week low
10.84 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
17.53
Price/Book Value
3.9189
Enterprise Value
891.03M usd
EV/Revenue
16.7408
EV/EBITDA
8.8241

Key financials

Revenue TTM
53.22M usd
Gross Profit TTM
26.16M usd
EBITDA TTM
3.97M usd
Earnings per Share
N/A usd
Dividend
0.04 usd
Total assets
361.81M usd
Net debt
39.87M usd

About

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    290650.KQ
  • Exchange
    KQ
  • Isin
    KR7290650001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Mr. Chul Lee Whan
  • Headquarter
    Seongnam-si
  • Web site
    https://www.lncbio.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top